- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07788521
Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® Multifocal
This study is a 4-visit, multi-site, prospective, controlled, randomized, single-masked (subjects), two-arm parallel group, bilateral, dispensing clinical trial to compare the performance of the Test lens to the Control lens in terms of safety and efficacy.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Study Contact
- Número de telefone: 1-800-843-2020
- E-mail: tkarkkai@its.jnj.com
Locais de estudo
-
-
Florida
-
Longwood, Florida, Estados Unidos, 32779
- Concluído
- Pearson Research Center PA
-
-
Georgia
-
Roswell, Georgia, Estados Unidos, 30076
- Ativo, não recrutando
- VisualEyes
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63144
- Ativo, não recrutando
- The Koetting Associates
-
-
New York
-
Jamestown, New York, Estados Unidos, 14701
- Recrutamento
- Spectrum Eyecare
-
Manhattan, New York, Estados Unidos, 10022
- Recrutamento
- Center for Ophthalmic and Vision Research/Eye Associates of New York
-
Vestal, New York, Estados Unidos, 13850
- Ativo, não recrutando
- Sacco Eye Group
-
-
Rhode Island
-
Warwick, Rhode Island, Estados Unidos, 02888
- Ativo, não recrutando
- Dr. David W. Ferris & Associates
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38119
- Concluído
- Total Eye Care
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Recrutamento
- Paradigm Research Center, LLC
-
Tyler, Texas, Estados Unidos, 75703
- Ativo, não recrutando
- Tyler Eye Associates
-
-
Virginia
-
Salem, Virginia, Estados Unidos, 24153
- Recrutamento
- Botetourt Eyecare, LLC
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
- Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
- Appear able and willing to adhere to the instructions set forth in this clinical protocol.
- Be at least 40 years of age and not greater than 70 years of age at the time of consent.
- Own a wearable pair of spectacles if required for their distance vision.
- Be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 2 days per week for at least 6 hours per wear day, for 30 days or more duration).
- Either already be wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".
- The subject's distance spherical equivalent refraction (vertex corrected if ≥-4.25 D) must be in the range of -1.50 D to -5.50 D in each eye.
- The subject's refractive cylinder must be ≤0.75 D in each eye.
- The subject's ADD power must be in the range of +0.75 D to +2.50 D.
- The subject must have distance best corrected visual acuity of 0.0 logMAR (20/20 Snellen, 5.0 on the China standard 5-point logMAR visual acuity scale) or better in each eye.
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
- Be currently pregnant or lactating.
- Have any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.
- Have been diagnosed with diabetes.
- Have any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens-Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).
- Have any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, dacryocystorhinostomy, peripheral iridotomy/iridectomy, cataract surgery, retinal surgery, etc.).
- Have a history of amblyopia, strabismus or binocular vision abnormality.
- Use of any of the following medications within 1 week prior to enrollment: oral retinoid, oral tetracyclines, anticholinergics, oral phenothiazines, oral/inhaled corticosteroids.
- Use of any ocular medication.
- Have a history of herpetic keratitis.
- Have a history of irregular cornea.
- Have a history of pathological dry eye.
- Have a history of glaucoma or glaucoma suspect.
- Have a history of any retinal disease/condition that may interfere with any of the study assessments or are not stable and have potential to progress during the study.
- Have participated in any contact lens or lens care product clinical trial within 15 days prior to study enrollment.
- Be an employee (e.g., Investigator, Coordinator, Technician) or immediate family member of an employee (including partner, child, parent, grandparent, grandchild, sibling of the employee or their spouse) of the clinical site.
- Have any known hypersensitivity or allergic reaction to sodium fluorescein.
- Have Grade 3 or greater palpebral conjunctival observations or Grade 2 or greater slit lamp findings (e.g. corneal edema, corneal vascularization, corneal staining, bulbar injection, etc.) on the ISO 11980 classification scale, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.
- Have any current ocular infection or inflammation.
- Have intraocular pressure in one or both eyes >21mmHg
- Have signs of any retinal disease/conditions that may interfere with any of the study assessments or are not stable and have potential to progress during the study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Senofilcon A
Eligible subjects will be randomized to the Senofilcon A Lens for the duration of the study. |
ACUVUE® Oasys MAX 1-Day Multifocal |
|
Comparador Ativo: Nelfilcon A
Eligible subjects will be randomized to the Nelfilcon A Lens for the duration of the study. |
DAILIES® AquaComfort Plus® Multifocal |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incidence rate of study-lens related (i.e. related and possibly related) ocular adverse events.
Prazo: Up to 1-month follow-up
|
Up to 1-month follow-up
|
|
|
Mean binocular HLHC distance Visual Acuity
Prazo: At 1-week follow-up
|
Mean binocular HLHC VA at distance (4m) |
At 1-week follow-up
|
|
Mean binocular HLHC Intermediate Visual Acuity
Prazo: At 1-week follow-up
|
Mean binocular HLHC VA at Intermediate (64cm) |
At 1-week follow-up
|
|
Mean binocular HLHC Near Visual Acuity
Prazo: At 1-week follow-up
|
Mean binocular HLHC VA at Near (40cm) |
At 1-week follow-up
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Mean binocular HLHC distance Visual Acuity
Prazo: At 1-month follow-up
|
Mean binocular HLHC VA at distance (4m) |
At 1-month follow-up
|
|
Mean binocular HLHC Intermediate Visual Acuity
Prazo: At 1-month follow-up
|
Mean binocular HLHC VA at Intermediate (64cm) |
At 1-month follow-up
|
|
Mean binocular HLHC Near Visual Acuity
Prazo: At 1-month follow-up
|
Mean binocular HLHC VA at Near (40cm) |
At 1-month follow-up
|
|
Incidence rate of Slit Lamp Findings (SLF)
Prazo: Up to 1-month follow-up
|
Slit lamp findings will be assessed for each eye at all study visits (scheduled and unscheduled) by grade. SLFs will be evaluated and graded using the ISO 11980 Grading scale from 0 to 4, where Grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e., Grade 1 = trace, Grade 2 = mild, Grade 3 = moderate and Grade 4 = severe). |
Up to 1-month follow-up
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Johnson & Johnson Vision Care, Inc. Clinical Trial, Johnson & Johnson Vision Care, Inc.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- CR-6560
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Johnson & Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .